A Better Solution for Every Care Provider

Discover Spark Wearable Neurostimulation solutions to treat opioid withdrawal.

Flexible, Drug-Free Therapy, Better Patient Outcomes

Whether transitioning patients to MAT/MOUD or eliminating opioids from daily life, managing opioid withdrawal is a pivotal first step. It’s a critical moment - a chance to stabilize patients in withdrawal or risk losing them to an AMA discharge. Studies show approximately 10% of patients leave against medical advice in the first three days of treatment – many due to unmanaged withdrawal.

Spark Wearable Neurostimulation treatments with Sparrow Ascent are a better way forward for rapid and sustainable withdrawal management.

Sparrow Ascent - Neurostimulation for Addiction Management

Sparrow Ascent changes the way opioid withdrawal is managed, using a non-invasive, FDA-cleared solution that directly targets all withdrawal symptoms without drug interactions or systemic side effects.

Indication for Use: The Sparrow Ascent is a transcutaneous nerve field stimulator for patients experiencing opioid withdrawal in conjunction with standard symptomatic medication and other therapies for opioid withdrawal symptoms. Treatments are applied under the supervision of trained clinical personnel.

‍

Transcutaneous Auricular Neurostimulation (tAN®) FDA-cleared, prescription, wearable neurostimulation for opioid withdrawal relief.

A Better Solution for All Kinds of Care Providers

Spark Neurostimulation is a proven solution for a range of Addiction Disorder treatment providers.

Woman explaining medical science in white labcoat

State Hospitals and Care Providers

For state hospitals and other non-specialty care providers, providing effective treatment for Addiction Disorders can be tricky with high AMA abandonment rates and confusing reimbursement policies. Sparrow Ascent makes treating opioid withdrawal simpler, with higher patient treatment compliance that leads to better outcomes.

Veterans Affairs Health Providers

Opioid withdrawal can be a significant obstacle for veterans - physical and emotional symptoms can feel insurmountable, leaving many vets stuck in a spiral of dependence. Sparrow Ascent gives our veterans the ally they deserve in their fight against opioid withdrawal.

Indian Health Providers

Mortality rates for AI/AN populations are 3.5X the national average, and Addiction Disorders disproportionately affect these communities. Sparrow Ascent provides an effective and drug-free solution that can be a lifesaver in MAT-scarce tribal contexts.

Addiction Treatment Centers

For addiction centers, Sparrow Ascent expands the treatment arsenal with drug-free, tech-enabled care. It's a solution that can be both effective and cost efficient, helping ensure patient compliance and lowering the risk of AMA departures during withdrawal therapy.

Woman wearing Sparrow Ascent device in kitchen

What Makes Sparrow Ascent Different?

As the first FDA-cleared, non-invasive, wearable neurostimulation device for opioid withdrawal relief, Sparrow Ascent delivers:

A Drug-Free/Non-Invasive Option: No systemic side effects, no drug interactions, no needles, no surgery.

Rapid Activation: Begins working in as little as 30 minutes; 84% of patients report mild to no symptoms within an hour.

Proven Efficacy: 100% of participants in clinical trials sustained meaningful relief at day 3 and beyond.

Withdrawal Management - Clinical Advantages

Sparrow Ascent minimizes key obstacles that can cause withdrawal-related treatment disruption.

Reduces Early Discharges
A proven tool that lowers withdrawal-related, against medical advice, discharge rate in the first three days.

Optimizes Provider Resources
Reduce high acuity patient burden on staff with a safe, fast-acting, flexible approach to withdrawal management.

Enhances Ongoing Patient Engagement
90% of patients that complete detox with Sparrow Ascent continued to the next treatment step.

Maximizes Patient Access
Sparrow Ascent can be used across IP, OP, and in-home care settings, allowing unique treatment options not yet offered by other centers.

Results by the Numbers

84%

of participants experienced mild or no withdrawal symptoms after 60 minutes of therapy.

100%

of participants sustained a clinically meaningful reduction in withdrawal symptoms by day three.

9/10

participants who completed detox accepted a referral to continue opioid use disorder treatment.

Additional Resources

Explore the latest news from Spark Biomedical and access our library of publications, research, and user testimonials.

To receive information on how Sparrow Ascent fits your patients, complete the form below.